Koyfin Home > Directory > Health Care > Acorda Therapeutics > Long-Term Debt / Capital

Acorda Therapeutics Long-Term Debt / Capital Chart (ACOR)

Acorda Therapeutics annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Acorda Therapeutics Long-Term Debt / Capital for the quarter ending June 06, 2020 was $33m a -72.87% decrease of -24m year over year
  • Acorda Therapeutics Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $33m a -72.87% decrease of -24m year over year
  • Acorda Therapeutics Annual Long-Term Debt / Capital for 2019 was $43m a 16.60% increase of 7m from 2018
  • Acorda Therapeutics Annual Long-Term Debt / Capital for 2018 was $36m a -8.95% decrease of -3m from 2017
  • Acorda Therapeutics Annual Long-Term Debt / Capital for 2017 was $39m a 16.77% increase of 7m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Long-Term Debt / Capital Data

06/2020$33m
03/2020$43m
12/2019$43m
09/2019$56m
06/2019$40m
03/2019$39m
12/2018$36m
09/2018$36m
06/2018$36m
03/2018$38m

Annual ACOR Long-Term Debt / Capital Data

2019$43m
2018$36m
2017$39m
2016$33m
2015$33m
2014$35m
2013$1m
2012$1m
2011$2m
2010$4m